Category:Monoclonal antibodies
From WikiMD.com - Food, Medicine & Wellness Encyclopedia
Subcategories
This category has the following 2 subcategories, out of 2 total.
Pages in category "Monoclonal antibodies"
The following 200 pages are in this category, out of 563 total.
(previous page) (next page)A
- Abciximab
- Abituzumab
- Abrilumab
- Acetryptine
- Actoxumab
- Adalimumab
- Adc
- ADC-3680
- Adecatumumab
- Aducanumab
- Afelimomab
- Afucosylated monoclonal antibodies
- Alacizumab pegol
- Alemtuzumab
- Alirocumab
- Amatuximab
- Amivantamab
- Anatumomab mafenatox
- Andecaliximab
- Anifrolumab
- Anrukinzumab
- Ansuvimab
- Anti-CD3 monoclonal antibody
- Antibody–drug conjugate
- Apolizumab
- ARGX-109
- Arkansas wine
- Ascrinvacumab
- Aselizumab
- Atoltivimab
- Atoltivimab, maftivimab, and odesivimab-ebgn
- Atoltivimab/maftivimab/odesivimab
B
- Bamlanivimab/etesevimab
- Bapineuzumab
- Bavituximab
- Bectumomab
- Bedinvetmab
- Belimumab
- Benralizumab
- BerEp4
- Bertilimumab
- Besilesomab
- Bezlotoxumab
- BIIB033
- Bimagrumab
- Bimekizumab
- Bivatuzumab
- Bleselumab
- Blosozumab
- Bococizumab
- Brazikumab
- Brentuximab vedotin
- Briakinumab
- Brilanestrant
- Brofaromine
- Brolucizumab
- Brontictuzumab
- Budipine
- Bufuralol
- Bunaftine
- Burosumab
C
- Camidanlumab tesirine
- Camrelizumab
- Candoxatril
- Canrenoic acid
- Cantuzumab
- Caplacizumab
- Caplacizumab-yhdp
- Carbasalate calcium
- Carisbamate
- Carlumab
- Carmofur
- Carotuximab
- Carpindolol
- Casirivimab/imdevimab
- Catumaxomab
- Cedelizumab
- Cefaloglycin
- Cefmetazole
- Cefuzonam
- Cemiplimab
- Cericlamine
- Ceronapril
- Certolizumab pegol
- Chlorphenesin carbamate
- Chlorphenoxamine
- Cilnidipine
- Cimetropium bromide
- Cirmtuzumab
- Citatuzumab bogatox
- Cixutumumab
- Clazakizumab
- Clenoliximab
- Clevegen
- Clometocillin
- Cloxestradiol acetate
- Cobicistat
- Conatumumab
- Crenezumab
- Crizanlizumab
- CUMYL-PINACA
D
- Dacetuzumab
- Daclizumab
- Dacuronium bromide
- Dalotuzumab
- Dapirolizumab pegol
- Daratumumab
- Daratumumab/hyaluronidase
- Dazopride
- Decernotinib
- Demcizumab
- Denintuzumab mafodotin
- Denosumab
- Detumomab
- Developmental Studies Hybridoma Bank
- Dexbrompheniramine
- Dexbudesonide
- Dexelvucitabine
- Dexpramipexole
- Dic
- Dicycloplatin
- Difenpiramide
- Diflorasone
- Dihydroergocryptine
- Dimetofrine
- Dinutuximab
- Dipropanoylmorphine
- Diridavumab
- Disitamab vedotin
- Doisynoestrol
- Domagrozumab
- Domoprednate
- Donanemab
- Dostarlimab
- Drozitumab
- Duligotuzumab
- Dupilumab
- Durvalumab
- Dusigitumab
- Duvortuxizumab
E
- Ecromeximab
- Eculizumab
- Edobacomab
- Edrecolomab
- Efinaconazole
- Efungumab
- Eganelisib
- Eldelumab
- Elipovimab
- Elsilimomab
- Emactuzumab
- Emapalumab
- Emibetuzumab
- Emicizumab
- Enavatuzumab
- Enfortumab vedotin
- Template:Engineered antibodies
- Enoblituzumab
- Enokizumab
- Enoticumab
- Ensituximab
- Epanolol
- Epratuzumab
- Eptinezumab
- Erenumab
- Erlizumab
- Ertumaxomab
- Estradiol hemisuccinate
- Estradiol propoxyphenylpropionate
- Ethotoin
- Etifoxine
- Etrolizumab
- Etynodiol
- Evinacumab
- Evolocumab
- Exbivirumab
